Quanterix (QTRX) Cash from Operations Growth (1y) (2018 - 2026)
Quanterix (QTRX) Cash from Operations Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn | -84.38% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | 16.00% |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 185.96% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn | 122.43% |
| 10 | Quanterix | 173.35 Mn | 74.09 Mn | 15.57 Mn | -30.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.38% |
| Dec 31, 2025 | -282.24% |
| Sep 30, 2025 | -617.75% |
| Jun 30, 2025 | -14.22% |
| Mar 31, 2025 | 31.12% |
| Dec 31, 2024 | 30.52% |
| Sep 30, 2024 | -48.65% |
| Jun 30, 2024 | -579.28% |
| Mar 31, 2024 | -105.25% |
| Dec 31, 2023 | -51.39% |
| Sep 30, 2023 | 73.89% |
| Jun 30, 2023 | 112.98% |
| Mar 31, 2023 | 54.84% |
| Dec 31, 2022 | 59.12% |
| Sep 30, 2022 | -7.46% |
| Jun 30, 2022 | 18.34% |
| Mar 31, 2022 | -54.41% |
| Dec 31, 2021 | -315.00% |
| Sep 30, 2021 | -85.70% |
| Jun 30, 2021 | -31.37% |